HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Ardehali Selected Research

Biological Products

7/2008Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Ardehali Research Topics

Disease

6Bronchiolitis Obliterans Syndrome
02/2016 - 09/2008
4Infections
02/2012 - 02/2001
3Pulmonary Hypertension
06/2014 - 08/2001
1Wounds and Injuries (Trauma)
01/2017
1Primary Graft Dysfunction
02/2016
1Virus Diseases (Viral Diseases)
02/2012
1Systemic Scleroderma (Systemic Sclerosis)
10/2010
1Vascular Remodeling
09/2008
1Bronchiolitis
09/2008
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2006
1Heart Failure
08/2001
1Stroke (Strokes)
08/2001
1Bronchiolitis Obliterans
02/2001
1Organizing Pneumonia
02/2001
1Ischemia
06/2000

Drug/Important Bio-Agent (IBA)

2LigandsIBA
01/2017 - 02/2012
2ChemokinesIBA
02/2012 - 06/2000
1Prostaglandins DIBA
02/2016
1Biomarkers (Surrogate Marker)IBA
02/2012
1Chemokine ReceptorsIBA
02/2012
1Biological ProductsIBA
07/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2001

Therapy/Procedure

8Lung Transplantation
02/2016 - 02/2001
3Transplantation
06/2014 - 08/2001
1Heart Transplantation (Grafting, Heart)
08/2001